Epohelmins A and B, novel lanosterol synthase inhibitors from a fungal strain FKI-0929

21Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

From a fungal strain FKI-0929, two compounds designated epohelmins A and B, were isolated as new natural products with inhibitory activity against recombinant human lanosterol synthase. The crude extract from the whole broth of this strain was fractionated by silica gel column chromatography and HPLC to afford two isolated inhibitors. Detailed spectroscopic analyses led to the identification of their structures. They are diastereomers of 4,5-epoxy-2-(4′-oxoundec-(5′ E)-enyl)-heptamethylenamines, and their relative stereochemical configurations were determined as (2R, 4R, 5R) or (2S, 4S, 5S) for epohelmin A, and (2R, 4S, 5R) or (2S, 4R, 5S) for epohelmin B, respectively. These compounds inhibited recombinant human lanosterol synthase with IC50 values of 10 and 6.0 μM, respectively.

Cite

CITATION STYLE

APA

Sakano, Y., Shibuya, M., Yamaguchi, Y., Masuma, R., Tomoda, H., Omura, S., & Ebizuka, Y. (2004). Epohelmins A and B, novel lanosterol synthase inhibitors from a fungal strain FKI-0929. Journal of Antibiotics, 57(9), 564–568. https://doi.org/10.7164/antibiotics.57.564

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free